TipRanks
China Resources Pharmaceutical Group Ltd. (DE:640)
FRANKFURT:640
Germany Market
640
China Resources Pharmaceutical Group Ltd.
RESEARCH TOOLSreports

China Resources Pharmaceutical Group Ltd. (640) Income Statement

0 Followers

China Resources Pharmaceutical Group Ltd. Income Statement

Last quarter (Q2 2026), China Resources Pharmaceutical Group Ltd.'s total revenue was ¥153.28B, an increase of 9.99% from the same quarter last year. In Q2, China Resources Pharmaceutical Group Ltd.'s net income was ¥2.49B. See China Resources Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
HK$ 300.01BHK$ 274.18BHK$ 270.40B¥ 223.13B¥ 193.24B
Gross Profit
HK$ 49.53BHK$ 43.30BHK$ 42.43B¥ 34.36B¥ 28.87B
Operating Expenses
HK$ 35.63BHK$ 30.73BHK$ 30.52B¥ 24.87B¥ 21.32B
Depreciation and Amortization
HK$ 3.62BHK$ 2.70BHK$ 3.16B¥ 2.77B¥ 2.30B
EBITDA
HK$ 17.70BHK$ 15.45BHK$ 15.43B¥ 13.59B¥ 9.75B
Operating Income
HK$ 13.90BHK$ 12.56BHK$ 13.90B¥ 9.49B¥ 7.55B
Other Income/Expenses
HK$ -774.39MHK$ -931.88MHK$ -2.97B¥ -840.13M¥ -685.79M
Pretax Income
HK$ 13.13BHK$ 11.63BHK$ 10.94B¥ 8.65B¥ 6.86B
Net Income
HK$ 4.50BHK$ 3.57BHK$ 4.24B¥ 3.64B¥ 3.08B
Per Share Metrics
Basic EPS
HK$ 0.72HK$ 0.56HK$ 0.68¥ 0.55¥ 0.49
Diluted EPS
HK$ 0.72HK$ 0.56HK$ 0.68¥ 0.55¥ 0.49
Weighted Average Shares Outstanding
 6.28B 6.28B 6.28B 6.28B 6.28B
Weighted Average Shares Outstanding (Diluted)
 6.28B 6.28B 6.28B 6.28B 6.28B

China Resources Pharmaceutical Group Ltd. Earnings and Revenue History